Get started
RocketTickers

FDA Approves EYLEA® (aflibercept) Injection sBLA

Long
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)  
RocketTickers  
NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
Beyond Technical Analysis
2
0
beyondta
REGN: Regeneron Pharmaceuticals, Inc.
2018-08-17 07:00:00
FDA Approves EYLEA® (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.